SignatureFD’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.7K | Buy |
531
+8
| +2% | +$252 | ﹤0.01% | 2128 |
|
2025
Q1 | $17.1K | Sell |
523
-38
| -7% | -$1.24K | ﹤0.01% | 2127 |
|
2024
Q4 | $20.3K | Hold |
561
| – | – | ﹤0.01% | 2049 |
|
2024
Q3 | $17.5K | Hold |
561
| – | – | ﹤0.01% | 2095 |
|
2024
Q2 | $15K | Sell |
561
-96
| -15% | -$2.57K | ﹤0.01% | 2092 |
|
2024
Q1 | $22.4K | Sell |
657
-7
| -1% | -$239 | ﹤0.01% | 1944 |
|
2023
Q4 | $19.2K | Buy |
664
+221
| +50% | +$6.4K | ﹤0.01% | 1943 |
|
2023
Q3 | $12.2K | Buy |
443
+22
| +5% | +$607 | ﹤0.01% | 2094 |
|
2023
Q2 | $12.7K | Sell |
421
-32
| -7% | -$962 | ﹤0.01% | 2130 |
|
2023
Q1 | $16.4K | Sell |
453
-2
| -0.4% | -$72 | ﹤0.01% | 1975 |
|
2022
Q4 | $16.2K | Hold |
455
| – | – | ﹤0.01% | 1909 |
|
2022
Q3 | $15K | Buy |
455
+160
| +54% | +$5.28K | ﹤0.01% | 1886 |
|
2022
Q2 | $9K | Buy |
295
+4
| +1% | +$122 | ﹤0.01% | 2186 |
|
2022
Q1 | $9K | Hold |
291
| – | – | ﹤0.01% | 2214 |
|
2021
Q4 | $8K | Hold |
291
| – | – | ﹤0.01% | 2229 |
|
2021
Q3 | $8K | Hold |
291
| – | – | ﹤0.01% | 2187 |
|
2021
Q2 | $9K | Hold |
291
| – | – | ﹤0.01% | 2046 |
|
2021
Q1 | $8K | Hold |
291
| – | – | ﹤0.01% | 1964 |
|
2020
Q4 | $7K | Sell |
291
-34
| -10% | -$818 | ﹤0.01% | 1853 |
|
2020
Q3 | $7K | Buy |
325
+198
| +156% | +$4.27K | ﹤0.01% | 1781 |
|
2020
Q2 | $3K | Buy |
+127
| New | +$3K | ﹤0.01% | 2008 |
|
2020
Q1 | – | Sell |
-19
| Closed | – | – | 2419 |
|
2019
Q4 | $0 | Hold |
19
| – | – | ﹤0.01% | 2253 |
|
2019
Q3 | $1K | Hold |
19
| – | – | ﹤0.01% | 2012 |
|
2019
Q2 | $1K | Hold |
19
| – | – | ﹤0.01% | 1946 |
|
2019
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 1900 |
|
2018
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 1859 |
|
2018
Q3 | $1K | Hold |
19
| – | – | ﹤0.01% | 1836 |
|
2018
Q2 | $1K | Hold |
19
| – | – | ﹤0.01% | 1849 |
|
2018
Q1 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 1682 |
|